These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
215 related articles for article (PubMed ID: 25374567)
1. Vascular endothelium as a target of immune response in renal transplant rejection. Piotti G; Palmisano A; Maggiore U; Buzio C Front Immunol; 2014; 5():505. PubMed ID: 25374567 [TBL] [Abstract][Full Text] [Related]
2. Propagation and characterization of lymphocytes from transplant biopsies. Duquesnoy RJ; Trager JD; Zeevi A Crit Rev Immunol; 1991; 10(6):455-80. PubMed ID: 1830745 [TBL] [Abstract][Full Text] [Related]
3. Immunological function of the endothelial cell within the setting of organ transplantation. Taflin C; Charron D; Glotz D; Mooney N Immunol Lett; 2011 Sep; 139(1-2):1-6. PubMed ID: 21641935 [TBL] [Abstract][Full Text] [Related]
4. Lymphocyte subsets differentially induce class II human leukocyte antigens on allogeneic microvascular endothelial cells. Pardi R; Bender JR; Engleman EG J Immunol; 1987 Oct; 139(8):2585-92. PubMed ID: 3116086 [TBL] [Abstract][Full Text] [Related]
5. Endothelial cell antibodies associated with novel targets and increased rejection. Jackson AM; Sigdel TK; Delville M; Hsieh SC; Dai H; Bagnasco S; Montgomery RA; Sarwal MM J Am Soc Nephrol; 2015 May; 26(5):1161-71. PubMed ID: 25381426 [TBL] [Abstract][Full Text] [Related]
6. Donor-specific antibodies against HLA, MICA, and GSTT1 in patients with allograft rejection and C4d deposition in renal biopsies. Alvarez-Márquez A; Aguilera I; Gentil MA; Caro JL; Bernal G; Fernández Alonso J; Acevedo MJ; Cabello V; Wichmann I; Gonzalez-Escribano MF; Núñez-Roldán A Transplantation; 2009 Jan; 87(1):94-9. PubMed ID: 19136897 [TBL] [Abstract][Full Text] [Related]
7. Post transplant development of MICA and anti-HLA antibodies is associated with acute rejection episodes and renal allograft loss. Panigrahi A; Gupta N; Siddiqui JA; Margoob A; Bhowmik D; Guleria S; Mehra NK Hum Immunol; 2007 May; 68(5):362-7. PubMed ID: 17462503 [TBL] [Abstract][Full Text] [Related]
8. The emerging issue of MICA antibodies: antibodies to MICA and other antigens of endothelial cells. Stastny P; Zou Y; Fan Y; Qin Z; Lavingia B Contrib Nephrol; 2009; 162():99-106. PubMed ID: 19001817 [TBL] [Abstract][Full Text] [Related]
10. Vimentin antibodies: a non-HLA antibody as a potential risk factor in renal transplantation. Carter V; Shenton BK; Jaques B; Turner D; Talbot D; Gupta A; Chapman CE; Matthews CJ; Cavanagh G Transplant Proc; 2005 Mar; 37(2):654-7. PubMed ID: 15848491 [TBL] [Abstract][Full Text] [Related]
11. Functional assessment of immune markers of graft rejection: a comprehensive study in live-related donor renal transplantation. Panigrahi A; Deka R; Bhowmik D; Dash SC; Tiwari SC; Guleria S; Mehta SN; Mehra NK Clin Transplant; 2006; 20(1):85-90. PubMed ID: 16556160 [TBL] [Abstract][Full Text] [Related]
12. Antibodies against MICA antigens and kidney-transplant rejection. Zou Y; Stastny P; Süsal C; Döhler B; Opelz G N Engl J Med; 2007 Sep; 357(13):1293-300. PubMed ID: 17898098 [TBL] [Abstract][Full Text] [Related]
13. Mobilization of T lymphocytes following cardiac transplantation. Evidence that CD4-positive cells are required for cytotoxic T lymphocyte activation, inflammatory endothelial development, graft infiltration, and acute allograft rejection. Bishop DK; Shelby J; Eichwald EJ Transplantation; 1992 Apr; 53(4):849-57. PubMed ID: 1533070 [TBL] [Abstract][Full Text] [Related]
14. Tumor allograft rejection is mainly mediated by CD8+ cytotoxic T lymphocytes stimulated with class I alloantigens in cooperation with CD4+ helper T cells recognizing class II alloantigens. Tomita Y; Mayumi H; Eto M; Nomoto K J Immunol; 1990 Mar; 144(6):2425-35. PubMed ID: 1968930 [TBL] [Abstract][Full Text] [Related]
15. Cytokine-mediated induction of endothelial adhesion molecule and histocompatibility leukocyte antigen expression by cytomegalovirus-activated T cells. Waldman WJ; Knight DA Am J Pathol; 1996 Jan; 148(1):105-19. PubMed ID: 8546198 [TBL] [Abstract][Full Text] [Related]
16. Impact of human leukocyte antigen matching and recipients' panel reactive antibodies on two-year outcome in presensitized renal allograft recipients. Meng HL; Jin XB; Li XT; Wang HW; Lü JJ Chin Med J (Engl); 2009 Feb; 122(4):420-6. PubMed ID: 19302748 [TBL] [Abstract][Full Text] [Related]
17. The replacement of graft endothelium by recipient-type cells conditions allograft rejection mediated by indirect pathway CD4(+) T cells. Kapessidou Y; Habran C; Buonocore S; Flamand V; Barvais L; Goldman M; Braun MY Transplantation; 2006 Mar; 81(5):726-35. PubMed ID: 16534475 [TBL] [Abstract][Full Text] [Related]
18. The involvement of FcR mechanisms in antibody-mediated rejection. Lee CY; Lotfi-Emran S; Erdinc M; Murata K; Velidedeoglu E; Fox-Talbot K; Liu J; Garyu J; Baldwin WM; Wasowska BA Transplantation; 2007 Nov; 84(10):1324-34. PubMed ID: 18049118 [TBL] [Abstract][Full Text] [Related]
19. Donor non-specific MICA antibodies in renal transplant recipients. Sapák M; Chreňová S; Tirpáková J; Žilinská Z; Ďurmanová V; Shawkatová I; Jakuš V; Kuba D; Buc M Immunobiology; 2014 Feb; 219(2):109-12. PubMed ID: 24054943 [TBL] [Abstract][Full Text] [Related]
20. Association of de novo human leukocyte antigen and major histocompatibility complex class I chain-related gene-A antibodies and proteinuria with graft survival 5 years after renal transplantation. Zhang LW; Peng ZG; Xian WH; Cui XQ; Sun HB; Li EG; Geng LN; Zhao P; Tian J Transplant Proc; 2013 Nov; 45(9):3249-53. PubMed ID: 24182794 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]